At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 71 enrolled
Drug / intervention
RS-Series Rhinosinusitis Treatment System +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Balloon REmodeling Antrostomy THErapy Study (BREATHE I)
In Brief
A Phase 2 clinical trial evaluating RS-Series Rhinosinusitis Treatment System and FinESS Balloon for Sinusitis. Completed, enrolled 71 participants across 13 sites.
Detailed Summary
This study is designed to evaluate safety and effectiveness of a less invasive procedure to treat maxillary only, or maxillary and anterior ethmoid, chronic sinusitis. Additionally, this study will assess the feasibility of performing the procedure under local anesthesia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSinusitis
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2007
First PostedMar 2008
Primary CompletionJun 2010
TodayJul 2026
First PostedMar 28, 2008
Enrollment StartSep 1, 2007
Primary CompletionJun 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 18.3 years ago
Interventions
RS-Series Rhinosinusitis Treatment Systemdevice
Single arm
FinESS Balloondevice